Hypoalphalipoproteinemia in populations of Native American ancestry: An opportunity to assess the interaction of genes and the environment

Current Opinion in Lipidology

Volumn 20, Issue 2, 2009, Pages 92-97

  Aguilar Salinas, Carlos A ^a   Canizales Quinteros, Samuel ^b   Rojas Martfnez, Rosalba ^c   Mehta, Roopa ^a   Ma, Teresa Villarreal Molina ^b   Arellano Campos, Olimpia ^a   Riba, Laura ^b   Gómez Pérez, Francisco J ^a   Tusié Luna, Ma Teresa ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO DE CIENCIAS FÍSICAS   (Mexico)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

ABC A1; HDL cholesterol; Hispanics; Metabolic syndrome; Native americans

Indexed keywords

ABC TRANSPORTER A1; CARBOHYDRATE; FAT; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AFRICA; ALLELE; AMERICAN INDIAN; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CULTURAL FACTOR; DIETARY INTAKE; DISEASE PREDISPOSITION; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; ETHNIC GROUP; EUROPE; EVIDENCE BASED PRACTICE; GENE FREQUENCY; GENE INTERACTION; GENETIC ANALYSIS; GENETIC TRAIT; GENETIC VARIABILITY; HEALTH SURVEY; HEREDITY; HISPANIC; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOALPHALIPOPROTEINEMIA; INCIDENCE; LIPID METABOLISM; METABOLIC SYNDROME X; OBESITY; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOUTH AND CENTRAL AMERICA; SOUTH ASIA;

CHOLESTEROL, HDL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOALPHALIPOPROTEINEMIAS; INDIANS, NORTH AMERICAN; METABOLIC SYNDROME X;

EID: 64549120714     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283295e96     Document Type: Review

References (61)

1. Kuller LH. Ethnic differences in atherosclerosis, cardiovascular disease and lipid metabolism. Cur Opin Lipidol 2004; 15:109-113.
2. Palloni A, Morenoff JD. Interpreting the paradoxical in the hispanic paradox: demographic and epidemiologic approaches. Ann N Y Acad Sci 2001; 954:140-174.
3. Miech RA, Kim J, McConnell C, Hamman RF. A growing disparity in diabetes-related mortality U.S. trends, 1989-2005. Am J Prev Med 2009; 36:126-132.
4. Yusuf S, Reddy S, Ounpuu S, et al. Global Burden of Cardiovascular Diseases. Part II: Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001; 104:2855-2864.
5. Mensah GA, Mokdad AH, Ford ES, et al. State of disparities in cardiovascular health in the United States. Circulation 2005; 111:1233-1241.
6. Lopez-Jaramillo P. Detining the research priorities to fight the burden of cardiovascular diseases in Latin America. J Hypertens 2008; 26:1886-1889.
7. Lanas F, Avezum A, Bautista L, et al. Risk factors for acute myocardial infarction in Latin America. The INTERHEART Latin American Study. Circulation 2007; 115:1067-1074.
8. McQueen MJ, Hawken S, Wang X, et al. Lipids, lipoproteins, and apolipo-proteins as risk markers of myocardial infarction in 52 countries(the INTERHEART study): a case-control study. Lancet 2008; 372:224-233. The population-attributable risk of the ratio apolipoprotein B/apolipoprotein A-l for a cardiovascular event is described in a large case-control study including subjects of several ethnic groups.
9. Carroll M, Sempos C, Fulwood R, et al. Serum lipids and lipoproteins of Hispanics, 1982-84. Vital Health Stat 1990; 240:1-65.
10. Harris-Hooker S, Sanford GL. Lipids, lipoproteins and coronary heart disease in minority populations. Atherosclerosis 1994; 108(Suppl):S83-S104.
11. Carroll MD, Lacher DA, Sorlie PD, et al. Trends in serum lipids and lipoproteins of adults 1960-2002. JAMA 2005; 294:1773-1781.
12. Swenson CJ, Trepka MJ, Rewers MJ, et al. Cardiovascular disease mortality in Hispanics and non-Hispanic Whites. Am J Epidemiol 2002; 156:919-928.
13. Hunt KJ, Resendez RG, Williams K, et al. All-cause and cardiovascular mortality among Mexican-American and non-Hispanic White older participants in the San Antonio Heart Study-evidence against the 'Hispanic paradox'. Am J Epidemiol 2003; 158:1048-1057.
14. Bermudez O, Velez-Carrasco W, Schaeter EJ, Tucker KL. Dietary and plasma lipid, lipoprotein, and apolipoprotein profiles among elderly Hispanics and non-Hispanics and their association with diabetes. Am J Clin Nutr 2002; 76:1214-1221.
15. Leino A, Impivaara O, Kaitsaari M, et al. Serum concentrations of apolipoprotein A-l, apolipoprotein B and lipoprotein (a)in a population sample. Clin Chem 1995; 41:1633-1636.
16. Houterman S, Verschuren WMM, Boersma-CobbaertF CM, et al. Trends in total and high density lipoprotein cholesterol and their determinants in the Netherlands between 1993 and 1997. Int J Epidemiol 2001; 30:1063-1070.
17. Bruckert E. Epidemiology of low HDL-cholesterol: results of studies and surveys. Eur Heart J Supplements 2006; 8(Suppl F):F1 7-F22.
18. De Azeredo Passos VM, Barrero SM, Diniz LM, et al. Type 2 diabetes: prevalence and associated factors in a Brazilian community- the Bambui health and aging study. Sao Paulo Med J 2005; 123:66-71.
19. Aguilar-Salinas CA, Olaiz G, Valles V, et al. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res 2001; 42:1298-1307.
20. Barquera S, Flores M, Olaiz-Fernȧndez, et al. Dyslipidemias and obesity in Mexico. Salud Pública Mex 2007; 49:S338-S347.
21. Choudhury S, Ueshima H, Kita Y, et al. Alcohol intake and serum lipids in a Japanese population. Int J Epidemiol 1994; 23:940-947.
22. Fong PC, Tarn SC, Tai Y, et al. Serum lipid and apolipoprotein distribution in Hong Kong Chinese. J Epidemiol Community Health 1994; 48:355-359.
23. Mahley RW, Erhan-Palaoglu K, Atak Z, et al. Turkish Heart Study: lipids, lipoproteins and apolipoproteins. J Lipid Res 1995; 36:839-859.
24. Rodriguez-Moran M, Guerrero-Romero F, Brito-Zurita O, et al. Cardiovascular risk factors and acculturation in Yaquis and Tepehuanos Indians from Mexico. Arch Med Res 2008; 39:352-357.
25. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA 2002; 287:356-359.
26. Patel JV, Kirby M, Hughes EA. The lipid audit: analysis of lipid management in two centers in Britain 2003. Br J Cardiol 2004; 11:214-217.
27. Verschuren WMM, Boerma GJ, Kromhout D. Total and HDL-cholesterol in the Netherlands: 1987-1992. Levels and changes over time in relation to age, gender and educational level. Int J Epidemiol 1994; 23:948- 956.
28. Lorenzo C, Gonzalez-Villalpando C, Williams J, et al. The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity. Diabetes Care 2005; 28: 2480-2485.
29. Mitchell BD, González Villalpando C, Arredondo Perez B, et al. Myocardial Infarction and cardiovascular risk factors in Mexico City and San Antonio, Texas. Arterioscler Thromb Vase Biol 1995; 15:721-725.
30. Mendevil CO, Sierrea ID, Pérez CE. Valoracion del riesgo cardiovascular global y prevalencia de dislipidemia segiin los criterios del NCEP-ATP-III en una poblacion adulta de Bogotá, Columbia. Clin Invest Arterioscl 2004; 16:99-107.
31. Ryder E, Silva E, Sulbarán T, et al. Black Hispanics have a worse cardiovascular risk profile than mixed Hispanics in Venezuela. Invest Clin 2007; 48:45- 55.
32. Ferrante D, Virgolini M. Risk factor's national survey 2005:Main results. Prevalence of the cardiovascular risk factors in Argentina. Rev Argent Cardiol 2007; 75:20-29.
33. Juarez X, Benitez J, Quezada-Galdamez R, et al. Prevalence of the metabolic syndrome in an urban population of San Salvador. Revista de la Asociacion Latinoamericana de Diabetes 2006; 14:16-20.
34. Schargrodsky H, Hernandez-Hernandez R, Marcet Champagne B, et al. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med 2008; 121:58-65. The first population-based study that describes the prevalence of cardiovascular risk factor in several Latin American cities.
35. Stevens G, Dias RH, Kevin JA, et al. Characterizing the epidemiological transition in Mexico: National and subnational burden of diseases, injuries, and risk factors. PLoS Med 5: e125. doi:10.1371/journal. pmed.0050125. A careful joint analysis of epidemiological data that demonstrates the epidemiological transition that is occurring in México.
36. Rodriguez C, Pablos-Méndez A, Palmas W, et al. Comparison of modifiable determinants of lipids and lipoprotein levels among African-Americans, Hispanics, and Non-Hispanic Caucasians > or =65 years of age living in New York City. Am J Cardiol 2002; 89:178-183.
37. Barquera S, Hernandez-Barrera L, Tolentino ME, et al. Energy intake from beverages is increasing among Mexican adolescents and adults. J Nutr 2008; 138:2454-2461. A description of the dietary habits(with emphasis on the consumption of beverages)in a Mexican population-based nationwide survey.
38. Caballero AE. Type 2 diabetes in the Hispanic or Latino population: challenges and opportunities. Curr Opin Endocrinol Diabetes Obes 2007; 14:151-157.
39. Lorenzo C, Serrano-Rios M, Martinez-Larrad M, et al. Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III detinitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care 2006; 29:685-691.
40. Caballero AE. Diabetes in the Hispanic or Latino population: genes, environment, culture, and more. Curr Diab Rep 2005; 5:217-225.
41. Price A, Patterson N, Yu F, et al. A genomewide admixture map for Latino populations. Am J Hum Genet 2007; 80:1024-1036.
42. Merchant AT, Anand SS, Kelemen LE, et al. Carbohydrate intake and HDL in a multiethnic population. Am J Clin Nutr 2007; 85:225-230.
43. Welty TK, Lee ET, Yeh J, et al. Cardiovascular disease risk factors among American Indians. The Strong Heart Study. Am J Epidemiol 1995; 142:269- 287.
44. Aguilar CA, Talavera G, Ordovas JM, et al. The apotipoprotein E4 allele is not associated with an abnormal lipid profile in a Native American population following its traditional lifestyle. Atherosclerosis 1999; 142:409-414.
45. McMurry MP, Connor WE, Cerqueira MT. Dietary cholesterol and the plasma lipids and lipoproteins in the Tarahumara Indians: a people habituated to a low cholesterol diet after weaning. Am J Clin Nutr 1982; 35:741-744.
46. Kathiresan S, Manning A, Demissie S, et al. A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study. BMC Medical Genetics 2007; 8(Suppl 1):S1-S17.
47. Holleboom AG, Vergeer M, Hovingh K, et al. The value of HDL genetics. Cur Opin Lipidol 2008; 19:385-394.
48. Scanu AM, Edelstein C. HDL: bridging past and present with a look at the future. FASEB J 2008; 22:4044-4054.
49. Kooner J, Chambers JC, Aguilar-Salinas CA, et al. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat Genet 2008; 40:149-151. The only high-density genome-wide association study related to lipid disorders in which a Hispanic population was included.
50. Wilier C, Sanna S, Jackson A, et al. Newly identified loci that influence lipid concentrations and risk of coronary heart disease. Nat Genet 2008; 40:161-169. Several newly identified loci linked with HDL cholesterol levels are reported in an European study including 6068 individuals, originally collected to identify diabetes genes.
51. Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008; 40:189-197. Six newly identified chromosomal regions, one with HDL cholesterol(1q42 in GALNT2)and five with triglycerides are reported in this genome-wide association study.
52. Kathiresan S, Wilier CJ, Peloso GM, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009; 41:56-65. A genome-wide association study that identifies association between the ANGPTL4, FADS1-FADS2-FADS3, HNF4A, LCAT, PLTP and TTC39B genes and HDL cholesterol levels in a large number of cases and controls.
53. Aulchenko YS, Ripatti S, Lindqvist I, et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 2009; 41:47-55. A genome-wide association study that describes the association between 22 loci and several lipid traits in a large number of cases and controls. However, genetic risk scores based on lipid loci explain up to 4.8% of variation in lipids.
54. Hunt KJ, Lehman DM, Arya R, et al. Genome-wide linkage analyses of type 2 diabetes in Mexican Americans: the San Antonio Family Diabetes/Gallbladder Study. Diabetes 2005; 54:2655-2662.
55. Santamaria A, Diego VP, Almasy L, et al. Quantitative trait locus on chromosome 12q14.1 influences variation in plasma plasminogen levels in the San Antonio Family Heart Study. Hum Biol 2007; 79:515-523.
56. Arya R, Duggirala R, Almasy L, et al. Linkage of high-density lipoprotein- cholesterol concentrations to a locus on chromosome 9p in Mexican Americans. Nat Genet 2002; 30:102-105.
57. Canizales S, Aguilar Salinas CA, Auron Gomez M, et al. Locus on chromosome 6p linked to elevated HDL-C serum levels, and to protection against premature atherosclerosis in a kindred with familial hypercholesterolemia. Circ Res 2003; 92:569-576.
58. Humphries SE, Berglund L, Isasi CR, et al. Loci for CETP, LPL, LIPC, and APOC3 affect plasma lipoprotein size and sub-population distribution in Hispanic and non-Hispanic white subjects: the Columbia University BioMar- kers Study. Nutr Metab Cardiovasc Dis 2002; 12:163-172.
59. Junyent M, Tucker KL, Smith CE, et al. The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican Health Study. J Lipid Res 2008[Epub ahead of print]
60. Villarreal-Molina MT, Aguilar-Salinas CA, Rodriguez-Cruz M, et al. The ABCA1 R230C variant affects HDL cholesterol levels and body mass index in the Mexican population: association with obesity and obesity-related comorbidities. Diabetes 2007; 56:1881-1887. This study reports the ethnic-specific association of the R230C variant of the ABC-A1 gene with hypoalphaliproteinemia in Mexican Mestizos and several Native American populations.
61. Villarreal-Molina MT, Flores-Dorantes MT, Arellano-Campos O, et al. Association of the ABCA1 R230C variant with early-onset type 2 diabetes in the Mexican population. Diabetes 2008; 57:509-513. The confirmation of the association of the R230C variant of the ABC-A1 gene with hypoalphaliproteinemia in a different Mexican cohort. In addition, an association with early onset type 2 diabetes is reported here.